Publishing research using ab141420? Please let us know so that we can cite the reference in this datasheet.

ab141420 has been referenced in 1 publication.

  • Kosovec JE  et al. CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease. Oncotarget 8:100421-100432 (2017). PubMed: 29245989

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up